These researchers demonstrated that an increased level of dysregulation in gene expression is present in GBM as compared to low-grade glioma, which further suggests the link between the differentially expressed clock-controlled genes and survival of the patients in case of both GBM and low-grade glioma (Petkovic et al., 2023a). This evidence concerns the gene CLOCK and central nervous system cancer.